What is he best known for?
The fields of study he is best known for:
His main research concerns Virology, Babesia, Babesia bovis, Microbiology and Babesia bigemina.
His Virology research integrates issues from Molecular biology, Antibody and Polymerase chain reaction, Nested polymerase chain reaction.
His biological study spans a wide range of topics, including Babesiosis, Diminazene and Parasitemia.
His Babesia bovis study combines topics in areas such as Rhoptry, Apicomplexa and Cell biology.
His Microbiology research incorporates elements of Toxoplasma gondii, In vitro and In vivo.
The various areas that Naoaki Yokoyama examines in his Babesia bigemina study include Apical membrane and Serology.
His most cited work include:
- Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond. (257 citations)
- Development of a multiplex loop-mediated isothermal amplification (mLAMP) method for the simultaneous detection of bovine Babesia parasites. (133 citations)
- Cell Cycle Regulation of Human CDC6 Protein INTRACELLULAR LOCALIZATION, INTERACTION WITH THE HUMAN MCM COMPLEX, AND CDC2 KINASE-MEDIATED HYPERPHOSPHORYLATION (108 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Virology, Babesia, Babesia bovis, Molecular biology and Babesiosis.
His Virology research includes elements of Gene, Recombinant DNA, Polymerase chain reaction, Antigen and Antibody.
His research in Babesia intersects with topics in In vivo, Parasitemia, Microbiology and Theileria.
His study looks at the relationship between Microbiology and fields such as In vitro, as well as how they intersect with chemical problems.
As a part of the same scientific study, Naoaki Yokoyama usually deals with the Babesia bovis, concentrating on Babesia bigemina and frequently concerns with Cattle Diseases.
His studies deal with areas such as Biochemistry, DNA, Blot, Complementary DNA and Western blot as well as Molecular biology.
He most often published in these fields:
- Virology (43.39%)
- Babesia (33.56%)
- Babesia bovis (33.22%)
What were the highlights of his more recent work (between 2018-2021)?
- Veterinary medicine (18.31%)
- In vitro (15.93%)
- Babesia (33.56%)
In recent papers he was focusing on the following fields of study:
Naoaki Yokoyama spends much of his time researching Veterinary medicine, In vitro, Babesia, Babesia bovis and Theileria.
His Veterinary medicine research includes themes of Livestock, Serology, Epidemiology and Theileria annulata.
His In vitro study combines topics from a wide range of disciplines, such as Clofazimine, Malaria, Pharmacology and Microbiology.
His work carried out in the field of Babesia brings together such families of science as Mefloquine, Artemisinin, Lumefantrine and Primaquine.
His work deals with themes such as IC50, Artesunate, Tafenoquine and Babesia bigemina, which intersect with Babesia bovis.
The concepts of his Theileria study are interwoven with issues in Cell division cycle, Atovaquone, Loop-mediated isothermal amplification, Parasitemia and In vivo.
Between 2018 and 2021, his most popular works were:
- Ellagic acid microspheres restrict the growth of Babesia and Theileria in vitro and Babesia microti in vivo. (25 citations)
- A Review on Equine Piroplasmosis: Epidemiology, Vector Ecology, Risk Factors, Host Immunity, Diagnosis and Control. (25 citations)
- Inhibitory effects of Syzygium aromaticum and Camellia sinensis methanolic extracts on the growth of Babesia and Theileria parasites (17 citations)
In his most recent research, the most cited papers focused on:
Naoaki Yokoyama mostly deals with Theileria, Babesia, In vitro, In vivo and Clofazimine.
The Theileria study combines topics in areas such as IC50 and Virology.
His IC50 study also includes fields such as
- Molecular biology that intertwine with fields like Antiprotozoal,
- EC50 together with Syzygium, Babesia bovis and Toxicity.
His Virology study integrates concerns from other disciplines, such as Ecology and Disease.
His In vitro research incorporates elements of Antioxidant, Malaria, Pharmacology and Imidocarb dipropionate.
The study incorporates disciplines such as Atovaquone, Combination chemotherapy and Parasitemia in addition to Clofazimine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
